Anilkumar; Gopinadhan N.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Anilkumar; Gopinadhan N..The latest application filed is for "tetracyclic indole derivatives and their use for treating or preventing viral infections".

Company Profile

0.17.12

Anilkumar; Gopinadhan N. - Edison NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted indole derivatives and methods of use thereof Grant 8,614,229 - Anilkumar , et al. December 24, 2	2013-12-24
4,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections Grant 8,557,848 - Chen , et al. October 15, 2	2013-10-15
4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections Grant 8,546,420 - Anilkumar , et al. October 1, 2	2013-10-01
2,3-substituted azaindole derivatives for treating viral infections Grant 8,404,845 - Anilkumar , et al. March 26, 2	2013-03-26
Heterocyclic substituted piperazines with CXCR3 antagonist activity Grant 8,207,170 - Kim , et al. June 26, 2	2012-06-26
2,3-substituted indole derivatives for treating viral infections Grant 8,143,305 - Anilkumar , et al. March 27, 2	2012-03-27
Tetracyclic Indole Derivatives And Their Use For Treating Or Preventing Viral Infections App 20110104109 - Bennett; Frank ; et al.	2011-05-05
Heterocyclic Substituted Piperazines With Cxcr3 Antagonist Activity App 20110065651 - Kim; Seong Heon ; et al.	2011-03-17
2,3-substituted Indole Derivatives For Treating Viral Infections App 20110033417 - Anilkumar; Gopinadhan N. ; et al.	2011-02-10
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity Grant 7,879,838 - Zeng , et al. February 1, 2	2011-02-01
Heterocyclic substituted piperazines with CXCR3 antagonist activity Grant 7,868,006 - Kim , et al. January 11, 2	2011-01-11
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,868,005 - Rosenblum , et al. January 11, 2	2011-01-11
2,3-substituted Azaindole Derivatives For Treating Viral Infections App 20100239527 - Anilkumar; Gopinadhan N. ; et al.	2010-09-23
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity Grant 7,799,789 - Anilkumar , et al. September 21, 2	2010-09-21
Pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity Grant 7,776,862 - McGuinness , et al. August 17, 2	2010-08-17
4, 5-ring Annulated Indole Derivatives For Treating Or Preventing Of Hcv And Related Viral Infections App 20100196319 - Anilkumar; Gopinadhan N. ; et al.	2010-08-05
Piperazine-piperidines with CXCR3 antagonist activity Grant 7,763,616 - Yu , et al. July 27, 2	2010-07-27
4,5-ring Annulated Indole Derivatives For Treating Or Preventing Of Hcv And Related Viral Infections App 20100098661 - Chen; Kevin X. ; et al.	2010-04-22
Novel Heterocyclic Substituted Pyridine Or Phenyl Compounds With Cxcr3 Antagonist Activity App 20080292589 - Anilkumar; Gopinadhan N. ; et al.	2008-11-27
Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity Grant 7,417,045 - Anilkumar , et al. August 26, 2	2008-08-26
Pyrazinyl substituted piperazine-piperidines with CXCR3 antagonist activity App 20070054919 - Rosenblum; Stuart B. ; et al.	2007-03-08
Heterocyclic substituted piperazines with CXCR3 antagonist activity App 20060276479 - Kim; Seong Heon ; et al.	2006-12-07
Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity App 20060276448 - Zeng; Qingbei ; et al.	2006-12-07
Piperazine-piperidines with CXCR3 antagonist activity App 20060276457 - Yu; Wensheng ; et al.	2006-12-07
Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity App 20060217392 - Anilkumar; Gopinadhan N. ; et al.	2006-09-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.